Status:
UNKNOWN
Prospective Cohort Study of Traditional Chinese Medicine for Survival of Patients With Early Breast Cancer
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Early-stage Breast Cancer
Eligibility:
FEMALE
20+ years
Brief Summary
This 2-year trial is intended to be used to study breast cancer patients through forward-looking generation design through collaboration between Chinese and Western medical teams. The whole study cons...
Detailed Description
Breast cancer is a major health issue for women worldwide and has increased exponentially in the last decades. Improved earlier detection combined with adjuvant systemic therapy is responsible for muc...
Eligibility Criteria
Inclusion
- Aged \> 20 years old female patients;
- Patients with histologically proven stage 1-3 breast cancer after surgery;
- The duration from the end of radical surgery to the beginning of the trail is less than 1 month;
- ECOG score is 0-2 points;
- Agreed to participate in this study and signed informed consent.
Exclusion
- Combined with inadequate heart, liver, kidney and hematopoietic function and other serious diseases;
- Pregnant and lactating women;
- Patients with a history of mental illness;
- Patients with distant metastasis and/or expected lifetime less than 3 months;
- Patients undergoing other medicinal herbs outside our hospital.
Key Trial Info
Start Date :
November 12 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 24 2020
Estimated Enrollment :
310 Patients enrolled
Trial Details
Trial ID
NCT03797248
Start Date
November 12 2018
End Date
October 24 2020
Last Update
September 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan, 83301